alexa The Level Of Receptor For Advanced Glycation End Products In The Serum Of Amyotrophic Lateral Sclerosis Patients Undergoing Stem Cell Experimental Treatment - Preliminary Study | 69927
ISSN: 2165-7939

Journal of Spine
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

CO-ORGANIZED EVENT:2nd International Conference on Spine and Spinal Disorders & 6th International Conference on Neurology and Neuromuscular Diseases

Mariusz Dziekonski, Judyta Juranek, Katarzyna Jezierska-Wozniak, Barczewska Monika, Siwek Tomasz, Stanislaw Maksymowicz, Marcin Jozwik, Mariola Swiderek-Matysiak, Maksymowicz Wojciech and Wojtkiewicz Joanna
University of Warmia and Mazury in Olsztyn, Poland
Clinical Logopedics and Social Sciences in Medicine, Poland
Medical University of Lodz, Poland
Foundation for the Nerve Cells Regeneration, Poland
Posters & Accepted Abstracts: J Spine
DOI: 10.4172/2165-7939-C1-006
Abstract
Amyotrophic lateral sclerosis (ALS) is fatal, neurodegenerative disorder affecting upper and lower motor neurons in the cerebral cortex, brainstem and spinal cord. Multiple factors are thought to contribute to the progression of ALS but its pathogenesis still remains unclear. Recent studies suggest that enhanced oxidative stress and neuroinflammation are involved in the progression of the disease. Mounting evidence implicates the receptor for advanced glycation end products (RAGE) as a significant contributor to the pathogenesis of certain neurodegenerative diseases and chronic conditions. Therefore, the aim of this study was to determine the level of RAGE in the serum of ALS patients treated with mesenchymal stem cells originating from Wharton’s jelly. Experimental group of patients included seven females and eight males (five – control and 10 – ALS patients, age range between 35-63 years). The level of RAGE in the serum after the first and third stem cells transplantation was measured using ELISA method. The obtained data has shown that the level of RAGE in the serum is significantly lower in the pateints with ALS than in the control group (847.51±91.56 vs. 401.83±67.55 and 523.70±95.17; p<0.01 and p<0.05, respectively). However, no changes were observed beetwen first and third transplantation of stem cells. In conclusion, it can be supposed that RAGE system might be involved in the course of ALS. The present study indicate that stem cells transplantation do not modulate the secretion of RAGE in the serum of ALS patients, but the further comprehensive studies need to be undertaken to cofirm this.
Biography

Mariusz Dziekoński is a PhD student in Department of Animal Physiology at University of Warmia and Mazury in Olsztyn (Poland). Now, he works as a Laboratory Technician in Department of Patophysiology, Faculty of Medical Sciences, University of Warmia and Mazury in Olsztyn (Poland) in the project “Innovative strategy for diagnostics, prevention and adiuvant therapy of selected neurodegenerative disorders in population of polish ancestry”.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7